Compare APWC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APWC | DYAI |
|---|---|---|
| Founded | 1996 | 1979 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.1M | 30.2M |
| IPO Year | 1997 | 2004 |
| Metric | APWC | DYAI |
|---|---|---|
| Price | $1.86 | $0.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 17.2K | ★ 527.8K |
| Earning Date | 08-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $492,001,000.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | N/A | $92.04 |
| P/E Ratio | $13.28 | ★ N/A |
| Revenue Growth | ★ 5.10 | N/A |
| 52 Week Low | $1.36 | $0.71 |
| 52 Week High | $2.34 | $2.20 |
| Indicator | APWC | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 54.19 | 35.96 |
| Support Level | $1.74 | $0.89 |
| Resistance Level | $1.89 | $1.04 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 74.99 | 5.63 |
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, PRC, Hong Kong and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.